Skip to main content

Table 1 Demographic characteristics–overall and by treatmenta

From: The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions

 

Overall (N = 258)

Control (N = 62)

Snus trial (N = 64)

Nicorette trial (N = 67)

Ariva trial (N = 65)

Offered and tried the ST product (N = 115)

Offered but did not try the ST product (N = 81)

Race–white

65 %

66 %

67 %

66 %

60 %

68 %

59 %

Race–black

28 %

31 %

23 %

27 %

32 %

27 %

28 %

Race–other

7 %

3 %

9 %

7 %

8 %

5 %

12 %

Age–under 30 yearsb

38 %

27 %

36 %

39 %

51 %

44 %

38 %

Age–30 to 50 years

38 %

35 %

41 %

36 %

38 %

39 %

37 %

Age–over 50 yearsb

24 %

37 %

23 %

25 %

11 %

17 %

25 %

Female

44 %

39 %

41 %

51 %

45 %

38 %c

55 %

Income–below 30 K

57 %

56 %

63 %

49 %

58 %

54 %

60 %

Income–between 30 and 60 K

10 %

19 %

09 %

10 %

11 %

14 %

14 %

Income–over 60 K

15 %

10 %

11 %

13 %

17 %

10 %

10 %

Income–chose not to reveal

18 %

15 %

17 %

27 %

14 %

22 %

16 %

Moderately or very worried about future quality of life

61 %

61 %

59 %

64 %

58 %

62 %

59 %

Prior smokeless tobacco use

43 %

39 %

50 %

43 %

38 %

55 %c

28 %

Observations–NY

36 %

39 %

33 %

36 %

38 %

38 %

30 %

Observations–SC

34 %

35 %

36 %

37 %

29 %

32 %

37 %

Observations–PA

29 %

26 %

31 %

27 %

32 %

30 %

31 %

  1. aAuctions conducted from November 2010–November 2011
  2. bThe only demographic characteristics that differed across treatment groups at a significance level of 0.05 or less was the over 50 age group (p < 0.01). No other differences in demographic characteristics were found to be significant at the 5 % level using a chi-squared test
  3. cThe only demographic or background characteristics where there were statistically significant differences in the percentage who tried ST products was for females (p < 0.05) and for those who had used smokeless tobacco at some point in the past (p < 0.01)